Skip to main content
    I

    Indaptus Therapeutics Inc (INDP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.85
    +0.64 (+28.96%)

    Market Cap: $318.45M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(21/37)
    Avg Surprise
    -3.10%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.02N/AN/ABeat+99.8%
    Dec 25
    Reported Mar 17
    		$-9.19$-4.36-110.78%Miss-2383.8%
    Sep 25
    Reported Nov 12
    		$-2.98$-4.17+28.54%Beat+66.7%
    Jun 25
    Reported Aug 13
    		$-9.09$-9.24+1.62%Beat+30.9%
    Mar 25
    Reported May 14
    		$-8.96$-5.04-77.78%Miss+28.9%
    Dec 24
    Reported Mar 13
    		$-0.37$-0.47+21.28%Beat+22.9%
    Sep 24
    Reported Nov 12
    		$-8.96$-13.16+31.91%Beat+31.9%
    Jun 24
    Reported Aug 12
    		$-13.16$-15.40+14.55%Beat-20.5%
    Mar 24
    Reported May 8
    		$-12.60$-15.96+21.05%Beat-2370.6%
    Dec 23
    Reported Mar 13
    		$-0.48$-0.54+11.11%Beat+96.1%
    Sep 23
    Reported Nov 6
    		$-13.16$-14.56+9.62%Beat-11.9%
    Jun 23
    Reported Aug 14
    		$-10.92$-16.24+32.76%Beat+15.2%
    Mar 23
    Reported May 11
    		$-0.51$-0.59+13.56%Beat-24.4%
    Dec 22
    Reported Mar 17
    		$-12.32$-14.56+15.38%Beat-100.0%
    Sep 22
    Reported Nov 10
    		$-11.76$-14.28+17.65%Beat+48.1%
    Jun 22
    Reported Aug 8
    		$-12.88$-12.04-6.98%Miss-132.9%
    Mar 22
    Reported May 12
    		$-0.41N/A+50.60%Beat+89.3%
    Dec 21
    Reported Mar 21
    		$-6.16N/A+63.33%Beat-190.6%
    Sep 21
    Reported Nov 15
    		$-22.68$-15.40-47.27%Miss-496.8%
    Jun 21
    Reported Aug 16
    		$-5.53$-2.56-116.02%Miss-38.3%
    Mar 21
    Reported May 17
    		$-3.84$-3.48-10.34%Miss+40.0%
    Dec 20
    Reported Mar 16
    		$-2.12$-3.40+37.65%Beat+85.3%
    Sep 20
    Reported Nov 5
    		$-3.80$-3.47-9.51%Miss+85.2%
    Jun 20
    Reported Aug 5
    		$-4.00$-4.27+6.32%Beat+83.3%
    Mar 20
    Reported May 11
    		$-6.40$-6.13-4.40%Miss+75.0%
    Dec 19
    Reported Mar 13
    		$-14.40$-12.00-20.00%Miss+51.4%
    Sep 19
    Reported Nov 12
    		$-25.60$-17.40-47.13%Miss-14.3%
    Jun 19
    Reported Aug 9
    		$-24.00$-24.16+0.66%Beat+11.8%
    Mar 19
    Reported May 7
    		$-25.60$-29.40+12.93%Beat+22.0%
    Dec 18
    Reported Feb 27
    		$-29.60$-24.16-22.52%Miss+2.6%
    Sep 18
    Reported Nov 9
    		$-22.40$-24.96+10.26%Beat+30.0%
    Jun 18
    Reported Aug 15
    		$-27.20$-26.08-4.29%Miss+27.7%
    Mar 18
    Reported May 15
    		$-32.80$-22.67-44.68%Miss-28.1%
    Dec 17
    Reported Mar 9
    		$-30.40$-22.00-38.18%Miss-
    Sep 17
    Reported Nov 15
    		$-32.00$-27.20-17.65%Miss-
    Jun 17
    Reported Aug 10
    		$-37.60$-24.80-51.61%Miss-
    Mar 17
    Reported Apr 7
    		$-25.60$-29.60+13.51%Beat-
    Dec 16
    Reported Mar 29
    		$0.00N/A+100.00%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-318.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio19.48xQuick Ratio19.48x
    Trading Statistics
    Beta0.97Avg Volume648.83K
    52-Week High$5.9652-Week Low$0.92

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.45
    SMA 20$2.87
    SMA 50$2.11
    SMA 200$2.28
    EMA 10$2.54
    EMA 20$2.59
    EMA 50$2.42
    EMA 200$2.88

    MACD

    Line: 0.00Signal: 0.08Hist: -0.07

    ADX

    ADX: 21.5+DI: 25.6-DI: 25.0

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down64.0
    PSAR$2.91

    Bollinger Bands

    Upper Band$4.16
    Lower Band$1.57
    %B Position9015%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    54.3

    Momentum Oscillators

    Stoch %K27.3
    Stoch %D22.8
    Williams %R-52.0
    ROC (10d)34.4%
    Momentum0.73
    CCI (20d)-25.5
    MFI (14d)51.3

    Volatility Measures

    ATR (14d)$0.42(14.7%)
    StdDev (20d)0.65
    Hist Vol209.9%(High)

    Volume Flow

    VWAP$2.66
    OBV486.2M
    AD Line52.7B
    CMF (20d)-0.040

    Volume Metrics

    Avg Vol (20d)607.6K
    Vol Ratio2.1x(High)
    VWMA (20d)$3.02

    Pivot Points

    R3$2.77
    R2$2.59
    R1$2.40
    Pivot Point$2.21
    S1$2.02
    S2$1.84
    S3$1.65

    Advanced Oscillators

    TSI0.35
    Ultimate Osc48.4
    KST494.25

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$1,470$0$0$0$1,928$0
    Cost of Revenue$0$0N/A$0$0$0$-735$0$0$0$320$0
    Gross Profit$0$0N/A$0$0$0$735$0$0$0$1,608$0
    Operating Expenses$1.81M$2.16M$8.16M$2.65M$4.46M$4.57M$4.17M$3.14M$4.11M$3.94M$4.18M$4.25M
    R&D$363,127$491,134$2.85M$1.52M$2.17M$2.81M$2.48M$1.47M$1.71M$1.59M$2.03M$2.23M
    SG&A$1.45M$1.67M$5.31M$1.13M$2.29M$1.76M$1.69M$1.68M$2.39M$2.35M$2.15M$2.02M
    Operating Income$-1,808,866$-2,159,588$-8,155,704$-2,648,487$-4,456,763$-4,572,559$-4,171,570$-3,142,057$-4,108,885$-3,943,239$-4,179,634$-4,248,412
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$381,482$40,129$365,718$787,703$0$230,180$0$0$0$0$0
    Income Before Tax$-1,808,866$-2,541,070$-8,195,833$-3,014,205$-5,244,466$-4,532,430$-4,401,750$-3,142,057$-4,015,267$-3,806,677$-4,002,780$-3,922,388
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,794,863$-2,541,070$-8,112,450$-2,975,117$-5,228,919$-4,532,430$-4,131,047$-3,069,036$-4,015,267$-3,806,677$-4,002,780$-3,922,388
    EBITDA$-1,808,866$-2,541,070$-8,195,833$-3,014,205$-5,244,466$-4,532,430$-4,401,750$-3,142,057$-4,015,267$-3,805,942$-4,002,460$-3,922,067
    EBIT$-1,808,866$-2,541,070$-8,195,833$-3,014,205$-5,244,466$-4,532,430$-4,401,750$-3,142,057$-4,015,267$-3,806,677$-4,002,780$-3,922,388
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INDP

    News

    Indaptus Therapeutics Announces Securities Purchase Agreements and Private Placement for $2.135 Million

    Indaptus Therapeutics has announced a private placement and securities purchase agreements to sell 1,817,017 shares of common stock and unregistered warrants for the same number of shares...

    Quiver Quantitative•10/5/26•Neutral

    Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16

    Indaptus Therapeutics (INDP) has extended the closing date for its $24 million private placement from September 29, 2026, to October 16...

    TradingView•9/30/26•Neutral

    Market Movers | Winners: VKTX, INDP, MAZE | Losers: XNDU, EVER, CLDX

    This article identifies top-performing and worst-performing US-listed stocks within the Trefis coverage universe over the last day, week, and month. It highlights companies like Viking Therapeutics (VKTX)...

    Trefis•9/23/26•Bullish

    Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com

    This article reports on a Form 8K filing by Indaptus Therapeutics Inc. for September 10th. It notes the stock symbol INDP and mentions a price performance of +8.20%. The content is brief...

    Investing.com Nigeria•9/10/26•Neutral

    Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com

    Investing.com reported on a Form 8K filing by Indaptus Therapeutics Inc. for September 10. The article mentions Indaptus Therapeutics Inc. (INDP) with a significant positive price change of 21.61%...

    Investing.com Canada•9/10/26•Neutral

    INDP Valuation and Fair Value

    P/B
    29.1x
    See GNG's fair value

    INDP Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -318.0%

    INDP Competitors

    CompanyTicker
    Canopy Growth CorpCGC
    Contineum Therapeutics, Inc. Class A Common StockCTNM
    Sanara Medtech IncSMTI
    QuantumSi IncQSI
    Arcturus Therapeutics Holdings IncARCT
    Movano IncMOVE
    Enanta Pharmaceuticals IncENTA
    Ocugen IncOCGN

    Sector: Healthcare

    INDP Bull Case vs Bear Case

    Bull case

    • INDP beat EPS estimates in 75.0% of its last 8 reported quarters.

    INDP Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -13.0%

    Frequently Asked Questions About INDP

    Does INDP pay dividends?

    Indaptus Therapeutics Inc (INDP) does not currently pay a regular dividend.

    What is INDP's market cap?

    Indaptus Therapeutics Inc (INDP) has a market capitalization of $318.45M with a current stock price of $2.85.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In